<html>
  <head></head>
  <body>
    <div id="title">
      <h2>"Point in Time" Regulation Content</h2>
      <h4>
        <em> Pharmacy Operations and Drug Scheduling Act </em>
      </h4>
      <h3 style="line-height: 110%">Drug Schedules Regulation</h3>
      <h3>B.C. Reg. 9/98</h3>
    </div>
    <table cellpadding="3" cellspacing="0" class="tablestyle3">
      <tbody
        xmlns:act="http://www.gov.bc.ca/2013/legislation/act"
        xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table"
        xmlns:xlink="http://www.w3.org/1999/xlink"
      >
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Acyclovir and its salts (in topical preparations in concentrations
            of 5% or less)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Acyclovir and its salts (except in topical preparations in
            concentrations of 5% or less)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Adrenocortical hormones and their salts and derivatives
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
            (except
            <br />
            (a) hydrocortisone or hydrocortisone acetate, when sold as a single
            medicinal ingredient in a concentration that provides 0.5% or less
            hydrocortisone in preparations for topical use on the skin, and
            <br />
            (b) clobetasone butyrate, when sold in a concentration of 0.05%
            clobetasone butyrate in cream preparations for topical use on the
            skin)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Azelaic acid</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Hydrocortisone
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
            (except when sold as a single medicinal ingredient in a
            concentration that provides 0.5% hydrocortisone in preparations for
            topical use on the skin)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Hydrocortisone (when sold as a single medicinal ingredient in a
            concentration that provides 0.5% hydrocortisone in preparations for
            topical use on the skin)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Hydrocortisone acetate
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
            (except when sold as a single medicinal ingredient in a
            concentration that provides 0.5% hydrocortisone in preparations for
            topical use on the skin)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Hydrocortisone acetate (when sold as a single medicinal ingredient
            in a concentration that provides 0.5% hydrocortisone in preparations
            for topical use on the skin)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Naproxen and its salts (except when sold for oral use with a daily
            dosage of 440 mg)
          </td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
